KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Change in Account Payables: 2013-2024

Historic Change in Account Payables for Biocryst Pharmaceuticals (BCRX) over the last 12 years, with Dec 2024 value amounting to -$62.4 million.

  • Biocryst Pharmaceuticals' Change in Account Payables rose 3.80% to $1.1 million in Q4 2015 from the same period last year, while for Dec 2015 it was $13.7 million, marking a year-over-year change of. This contributed to the annual value of -$62.4 million for FY2024, which is 271.17% down from last year.
  • Biocryst Pharmaceuticals' Change in Account Payables amounted to -$62.4 million in FY2024, which was down 271.17% from -$16.8 million recorded in FY2023.
  • Biocryst Pharmaceuticals' 5-year Change in Account Payables high stood at $39.4 million for FY2021, and its period low was -$62.4 million during FY2024.
  • For the 3-year period, Biocryst Pharmaceuticals' Change in Account Payables averaged around -$33.8 million, with its median value being -$22.4 million (2022).
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 127.09% in 2021, then plummeted by 271.17% in 2024.
  • Over the past 5 years, Biocryst Pharmaceuticals' Change in Account Payables (Yearly) stood at $17.4 million in 2020, then surged by 127.09% to $39.4 million in 2021, then slumped by 156.73% to -$22.4 million in 2022, then grew by 24.84% to -$16.8 million in 2023, then tumbled by 271.17% to -$62.4 million in 2024.